
Feature|Articles|June 19, 2026
How Will Emerging AI Impact the Pharmacy Benefit Manager Space?
Author(s)Brian Nowosielski
Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.
Advertisement
Advertisement
Artificial intelligence (AI) has risen as the key technology driving society forward through its innovation, touching almost all humans, industries, and populations. With its use increasing in real time across pharmacy, AI’s eventual introduction in the pharmacy benefits space was inevitable. The technology has quickly surpassed an investigational stage and into general use across the daily lives of millions. Experts are beginning to look into AI’s use among pharmacy benefit managers (PBMs) and how that will impact pharmacy operations.
Related to this article

Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.

Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.

Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.

Mark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.

Researchers say this net loss is unlikely to reverse without state and federal policy changes, including PBM reform.

Zaid Fadul, MD, FS, FAAFP, introduces the Nolla Derm app, what it might mean for pharmacists and their patients, and where AI prescribing is headed in the future.

Among a collection of patients across 15 pharmacies, researchers assessed acceptability and satisfaction with pharmacist-led clinical services.
Advertisement
Advertisement

